Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3878333 | 0.90 | FBP1 (0.36) | FBP1 | |
| SCHEMBL10408921 | 0.70 | ADORA1 (0.46) | — | |
| SCHEMBL27405630 | 0.68 | — | — | |
| SCHEMBL3417501 | 0.66 | GAA (0.31) | — | |
| SCHEMBL4481885 | 0.65 | CCNA2 (0.39) | — | |
| SCHEMBL4748203 | 0.63 | HPRT1 (0.36) | — | |
| SCHEMBL886934 | 0.63 | PDPK1 (0.40) | — | |
| SCHEMBL29708075 | 0.62 | PDPK1 (0.43) | — | |
| SCHEMBL3837871 | 0.62 | PDPK1 (0.43) | — | |
| SCHEMBL1924592 | 0.62 | PDPK1 (0.59) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12397058-B2 | Metabolically stable prodrugs | TSRL, INC. (US) | 2025-08-26 | — | — | US | claimed |
| US-12397058-B2 | Metabolically stable prodrugs | TSRL, INC. (US) | 2025-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12397058-B2 | Metabolically stable prodrugs | CES1, CES2, CYP2S1 | FBP1 218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.